Holen Sie sich die Stockscreener-App
2.38
1.71%
0.04
Vorhandelsmarkt:
2.38
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.34
Offen:
$2.35
24-Stunden-Volumen:
744.17K
Relative Volume:
0.82
Marktkapitalisierung:
$220.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.95M
KGV:
-5.1194
EPS:
-0.4649
Netto-Cashflow:
$-34.08M
1W Leistung:
-1.65%
1M Leistung:
-33.15%
6M Leistung:
-13.14%
1J Leistung:
-72.00%
1-Tages-Spanne:
$2.32
$2.43
1-Wochen-Bereich:
$2.27
$2.49
52-Wochen-Spanne:
$2.255
$10.38
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Firmenname
Anavex Life Sciences Corp
Sektor
Branche
Telefon
844-689-3939
Adresse
630 5TH AVENUE, NEW YORK
Compare AVXL vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
2.38 | 220.62M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Eingeleitet | Berenberg | Buy |
| 2021-09-23 | Eingeleitet | BTIG Research | Buy |
| 2020-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-02-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Eingeleitet | Janney | Buy |
| 2018-05-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-02-07 | Eingeleitet | Noble Financial | Buy |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
Alle ansehen
Anavex Life Sciences Corp Aktie (AVXL) Neueste Nachrichten
Anavex Life Sciences Corp. (AVXL) latest stock news and headlines - au.finance.yahoo.com
Anavex Life Sciences Corp. (AVXL) Stock Price, News, Quote & History - ca.finance.yahoo.com
Anavex Life Sciences Corp. (AVXL) stock price, news, quote and history - Yahoo Finance Singapore
Anavex Life Sciences Corp. (AVXL) Latest Stock News & Headlines - Yahoo! Finance Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - PR Newswire
Anavex stockholders elect six directors at annual meeting - Investing.com
Anavex Life Sciences (AVXL) Board Election Confirms Shareholder Confidence Amid Valuation Challenges - GuruFocus
Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting - The Manila Times
Anavex stockholders elect six directors at annual meeting By Investing.com - Investing.com Canada
Investigation launched into Anavex Life Sciences over alleged misleading business info affecting shareholders. - Pluang
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action InvestigationAVXL - TMX Newsfile
Investigation launched into Anavex Life Sciences over alleged misleading business info to investors - Pluang
Rosen Law Firm Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action InvestigationAVXL - morning-times.com
PVG takes Anavex (NASDAQ: AVXL) proxy campaign to investors online - Stock Titan
Activist outlines 100-day overhaul plan for Anavex (AVXL) - Stock Titan
PVG Asset Management Pushes Board Changes at Anavex Life Sciences (AVXL) Ahead of Proxy Vote - GuruFocus
PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences - The Manila Times
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring A 729.88% Potential Upside - DirectorsTalk Interviews
Anavex Life Sciences (AVXL) Faces Board Shakeup Amid Weak Valuation and Mixed Guru Interest - gurufocus.com
Glass Lewis says Anavex shareholders should vote for PVG Asset nominees - seekingalpha.com
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 17, 2026) - Stock Titan
Glass Lewis Recommends Anavex Stockholders Vote the GOLD Universal Proxy Card, Citing “Functionally Inert Stewardship” in Support of PVG Asset Management’s Call for Change - marketscreener.com
Glass Lewis Recommends Anavex Stockholders Vote the GOLD - GlobeNewswire
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 15, 2026) - Stock Titan
PVG Asset Management Believes ISS Acknowledges Anavex’s Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance - The Manila Times
ISS backs Anavex board nominees in proxy fight - Investing.com
Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote 'FOR” All Six of Anavex’s Highly Qualified Director Nominees - The Manila Times
ISS backs Anavex board nominees in proxy fight By Investing.com - Investing.com Canada
Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial By Investing.com - Investing.com Australia
PVG Asset Management Provides Information to Shareholders of Anavex Life Sciences - marketscreener.com
Six-seat board challenge at Anavex (AVXL) heads to investor call - Stock Titan
PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign - The Manila Times
CRM: Salesforce Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial - Investing.com Nigeria
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 9, 2026) - Stock Titan
Form 8K Anavex Life Sciences Corp For: 10 September By Investing.com - Investing.com Nigeria
Finanzdaten der Anavex Life Sciences Corp-Aktie (AVXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):